sr 95531 has been researched along with sch 23390 in 1 studies
| Studies (sr 95531) | Trials (sr 95531) | Recent Studies (post-2010) (sr 95531) | Studies (sch 23390) | Trials (sch 23390) | Recent Studies (post-2010) (sch 23390) |
|---|---|---|---|---|---|
| 610 | 0 | 209 | 803 | 0 | 585 |
| Protein | Taxonomy | sr 95531 (IC50) | sch 23390 (IC50) |
|---|---|---|---|
| D(2) dopamine receptor | Homo sapiens (human) | 1.0405 | |
| D | Rattus norvegicus (Norway rat) | 0.001 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 0.0461 | |
| D(1B) dopamine receptor | Homo sapiens (human) | 0.0011 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0006 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.3891 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leyrer-Jackson, JM; Thomas, MP | 1 |
1 other study(ies) available for sr 95531 and sch 23390
| Article | Year |
|---|---|
Dopaminergic D1 receptor effects on commissural inputs targeting layer V pyramidal subtypes of the mouse medial prefrontal cortex.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Dopamine Agonists; Dopamine Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; Mice; Neural Pathways; Prefrontal Cortex; Pyramidal Cells; Pyridazines; Receptors, Dopamine D1 | 2019 |